These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 30054848

  • 1. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
    Schmid I, Klenk AK, Sparber-Sauer M, Koscielniak E, Maxwell R, Häberle B.
    World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
    [Abstract] [Full Text] [Related]

  • 2. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Ji Y, Yang K, Peng S, Chen S, Xiang B, Xu Z, Li Y, Wang Q, Wang C, Xia C, Li L, Liu X, Lu G, Yang G, Wu H.
    Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
    [Abstract] [Full Text] [Related]

  • 3. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
    Tribolet S, Hoyoux C, Boon LM, Cheruy C, Demarche M, Jamblin P, Roberti A, Willemaers V, Viellevoye R, Rigo V, Broux I.
    Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
    [Abstract] [Full Text] [Related]

  • 4. Kaposiform hemangioendothelioma without cutaneous involvement.
    Ji Y, Chen S, Li L, Yang K, Xia C, Li L, Yang G, Kong F, Lu G, Liu X.
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2475-2484. PubMed ID: 30293120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
    Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor CC.
    J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
    [Abstract] [Full Text] [Related]

  • 7. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
    Wallenstein MB, Hole MK, McCarthy C, Fijalkowski N, Jeng M, Wong WB.
    Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
    [Abstract] [Full Text] [Related]

  • 8. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
    Oza VS, Mamlouk MD, Hess CP, Mathes EF, Frieden IJ.
    Pediatr Dermatol; 2016 Sep; 33(2):e88-92. PubMed ID: 26864138
    [Abstract] [Full Text] [Related]

  • 9. Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus.
    Schroeder U, Lauten M, Stichtenoth G, Gebhard MP, Buchholz M, Kaiser MM.
    Klin Padiatr; 2014 Nov; 226(6-7):362-8. PubMed ID: 24810750
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W, Lu G, Liu X, Xia C, Wang Q, Li Y, Wang C, Yang K, Yang G, Tang X, Xu T, Wu H.
    Int J Cancer; 2017 Aug 15; 141(4):848-855. PubMed ID: 28486787
    [Abstract] [Full Text] [Related]

  • 11. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
    Croteau SE, Gupta D.
    Semin Cutan Med Surg; 2016 Sep 15; 35(3):147-52. PubMed ID: 27607323
    [Abstract] [Full Text] [Related]

  • 12. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y, Chen S, Yang K, Xia C, Peng S.
    J Dermatol; 2018 Oct 15; 45(10):1203-1206. PubMed ID: 30118141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R, Uller W, Huf V, Müller-Wille R, Schmid I, Pohl A, Häberle B, Perkowski S, Funke K, Till AM, Lauten M, Neumann J, Güttel C, Heid E, Ziermann F, Schmid A, Hüsemann D, Meyer L, Sporns PB, Schinner R, Schmidt VF, Ricke J, Rössler J, Kapp FG, Wohlgemuth WA, Wildgruber M.
    Int J Cancer; 2021 May 01; 148(9):2345-2351. PubMed ID: 33231291
    [Abstract] [Full Text] [Related]

  • 15. Kaposiform haemangioendothelioma of the head and neck.
    Wong BL, Lee VN, Tikka T, Kim D, Dwivedi RC.
    Crit Rev Oncol Hematol; 2016 Aug 01; 104():156-68. PubMed ID: 27365122
    [Abstract] [Full Text] [Related]

  • 16. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
    Duan L, Renzi S, Weidman D, Waespe N, Chami R, Manson D, Cada M, Carcao M.
    J Pediatr Hematol Oncol; 2020 Jan 01; 42(1):74-78. PubMed ID: 30044355
    [Abstract] [Full Text] [Related]

  • 17. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J, Smink GM, Helm K, Xavier F.
    Pediatr Blood Cancer; 2018 Dec 01; 65(12):e27305. PubMed ID: 30070028
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M, Koscielniak E, Vokuhl C, Schmid I, Bien E, Seitz G, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Niggli F, Ljungman G, Fuchs J, Hettmer S, Rössler J, Klingebiel T, CWS Study Group.
    Pediatr Blood Cancer; 2020 Mar 01; 67(3):e28095. PubMed ID: 31814291
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.